A carregar...
Technical Advances in the Measurement of Residual Disease in Acute Myeloid Leukemia
Outcomes for those diagnosed with acute myeloid leukemia (AML) remain poor. It has been widely established that persistent residual leukemic burden, often referred to as measurable or minimal residual disease (MRD), after induction therapy or at the time of hematopoietic stem cell transplant (HSCT)...
Na minha lista:
| Publicado no: | J Clin Med |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5615280/ https://ncbi.nlm.nih.gov/pubmed/28925935 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm6090087 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|